Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1996 Feb 1;183(2):339–348. doi: 10.1084/jem.183.2.339

HLA-derived peptides which inhibit T cell function bind to members of the heat-shock protein 70 family

PMCID: PMC2192466  PMID: 8627147

Abstract

Synthetic peptides corresponding to sequences of HLA class I molecules have inhibitory effects on T cell function. The peptides investigated in this study have sequences corresponding to the relatively conserved region of the alpha 1 helix of HLA class I molecules that overlaps the "public epitope" Bw4/Bw6. These HLA-derived peptides exhibit inhibitory effects on T lymphocytes and have beneficial effects on the survival of allogenic organ transplants in mice and rats. Peptides corresponding to the Bw4a epitope appear most potent as they inhibit the differentiation of T cell precursors into mature cytotoxic T lymphocytes (CTL) and target cell lysis by established CTL lines and clones. To elucidate the mechanism through which these peptides mediate their inhibitory effect on T lymphocytes, peptide binding proteins were isolated from T cell lysates. We show that the inhibitory Bw4a peptide binds two members of the heat-shock protein (HSP) 70 family, constitutively expressed HSC70 and heat-inducible HSP70. Peptide binding to HSC/HSP70 is sequence specific and follows the rules defined by the HSC70 binding motif. Most intriguing, however, is the strict correlation of peptide binding to HSC/HSP70 and the functional effects such that only inhibitory peptides bind to HSC70 and HSP70 whereas noninhibitory peptides do not bind. This correlation suggests that small molecular weight HLA-derived peptides may modulate T cell responses by directly interacting with HSPs. In contrast to numerous reports of HSP70 expression at the surface of antigen-presenting cells and some tumor cells, we find no evidence that HSC/HSP70 are expressed at the surface of the affected T cells. Therefore, we believe that the peptides' immunodulatory effects are not mediated through a signaling event initiated by interaction of peptide with surface HSP, but favor a model similar to the action of other immunomodulatory compounds, FK506 and cyclosporin A, with a role for HSC/HSP70 similar to that for immunophilins, FKBPs and CyP40.

Full Text

The Full Text of this article is available as a PDF (1.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blumberg N., Triulzi D. J., Heal J. M. Transfusion-induced immunomodulation and its clinical consequences. Transfus Med Rev. 1990 Oct;4(4 Suppl 1):24–35. doi: 10.1016/s0887-7963(90)70239-8. [DOI] [PubMed] [Google Scholar]
  2. Buelow R., Veyron P., Clayberger C., Pouletty P., Touraine J. L. Prolongation of skin allograft survival in mice following administration of ALLOTRAP. Transplantation. 1995 Feb 27;59(4):455–460. [PubMed] [Google Scholar]
  3. Buxton S. E., Benjamin R. J., Clayberger C., Parham P., Krensky A. M. Anchoring pockets in human histocompatibility complex leukocyte antigen (HLA) class I molecules: analysis of the conserved B ("45") pocket of HLA-B27. J Exp Med. 1992 Mar 1;175(3):809–820. doi: 10.1084/jem.175.3.809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cella M., Longo A., Ferrara G. B., Strominger J. L., Colonna M. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med. 1994 Oct 1;180(4):1235–1242. doi: 10.1084/jem.180.4.1235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Christiansen F. T., Witt C. S., Ciccone E., Townend D., Pende D., Viale D., Abraham L. J., Dawkins R. L., Moretta L. Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: ancestral haplotypes encode particular NK-defined haplotypes. J Exp Med. 1993 Sep 1;178(3):1033–1039. doi: 10.1084/jem.178.3.1033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Clayberger C., Lyu S. C., DeKruyff R., Parham P., Krensky A. M. Peptides corresponding to the CD8 and CD4 binding domains of HLA molecules block T lymphocyte immune responses in vitro. J Immunol. 1994 Aug 1;153(3):946–951. [PubMed] [Google Scholar]
  7. Clayberger C., Lyu S. C., Pouletty P., Krensky A. M. Peptides corresponding to T-cell receptor-HLA contact regions inhibit class I-restricted immune responses. Transplant Proc. 1993 Feb;25(1 Pt 1):477–478. [PubMed] [Google Scholar]
  8. Clayberger C., Parham P., Rothbard J., Ludwig D. S., Schoolnik G. K., Krensky A. M. HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes. Nature. 1987 Dec 24;330(6150):763–765. doi: 10.1038/330763a0. [DOI] [PubMed] [Google Scholar]
  9. Clayberger C., Rosen M., Parham P., Krensky A. M. Recognition of an HLA public determinant (Bw4) by human allogeneic cytotoxic T lymphocytes. J Immunol. 1990 Jun 1;144(11):4172–4176. [PubMed] [Google Scholar]
  10. Cleveland D. W., Fischer S. G., Kirschner M. W., Laemmli U. K. Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem. 1977 Feb 10;252(3):1102–1106. [PubMed] [Google Scholar]
  11. Cuturi M. C., Josien R., Douillard P., Pannetier C., Cantarovich D., Smit H., Ménoret S., Pouletty P., Clayberger C., Soulillou J. P. Prolongation of allogeneic heart graft survival in rats by administration of a peptide (a.a. 75-84) from the alpha 1 helix of the first domain of HLA-B7 01. Transplantation. 1995 Mar 15;59(5):661–669. doi: 10.1097/00007890-199503150-00003. [DOI] [PubMed] [Google Scholar]
  12. D'Amaro J. W4(4a) and W6(4b) in diverse human populations. Demonstration of their genetic identity in population and segregation studies. Tissue Antigens. 1975 Jun;5(5):386–384. doi: 10.1111/j.1399-0039.1975.tb01482.x. [DOI] [PubMed] [Google Scholar]
  13. Davies H. S., Pollard S. G., Calne R. Y. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation. 1989 Mar;47(3):524–527. doi: 10.1097/00007890-198903000-00025. [DOI] [PubMed] [Google Scholar]
  14. Ferrarini M., Heltai S., Zocchi M. R., Rugarli C. Unusual expression and localization of heat-shock proteins in human tumor cells. Int J Cancer. 1992 Jun 19;51(4):613–619. doi: 10.1002/ijc.2910510418. [DOI] [PubMed] [Google Scholar]
  15. Fischer S. G. Peptide mapping in gels. Methods Enzymol. 1983;100:424–430. doi: 10.1016/0076-6879(83)00071-3. [DOI] [PubMed] [Google Scholar]
  16. Fourie A. M., Sambrook J. F., Gething M. J. Common and divergent peptide binding specificities of hsp70 molecular chaperones. J Biol Chem. 1994 Dec 2;269(48):30470–30478. [PubMed] [Google Scholar]
  17. Friedman J., Weissman I. Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: one in the presence and one in the absence of CsA. Cell. 1991 Aug 23;66(4):799–806. doi: 10.1016/0092-8674(91)90123-g. [DOI] [PubMed] [Google Scholar]
  18. Fruman D. A., Burakoff S. J., Bierer B. E. Immunophilins in protein folding and immunosuppression. FASEB J. 1994 Apr 1;8(6):391–400. doi: 10.1096/fasebj.8.6.7513288. [DOI] [PubMed] [Google Scholar]
  19. Fruman D. A., Klee C. B., Bierer B. E., Burakoff S. J. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci U S A. 1992 May 1;89(9):3686–3690. doi: 10.1073/pnas.89.9.3686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gething M. J., Sambrook J. Protein folding in the cell. Nature. 1992 Jan 2;355(6355):33–45. doi: 10.1038/355033a0. [DOI] [PubMed] [Google Scholar]
  21. Gumperz J. E., Litwin V., Phillips J. H., Lanier L. L., Parham P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med. 1995 Mar 1;181(3):1133–1144. doi: 10.1084/jem.181.3.1133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hoeger P. H., Tepper M. A., Faith A., Higgins J. A., Lamb J. R., Geha R. S. Immunosuppressant deoxyspergualin inhibits antigen processing in monocytes. J Immunol. 1994 Nov 1;153(9):3908–3916. [PubMed] [Google Scholar]
  23. Krensky A. M., Clayberger C. The induction of tolerance to alloantigens using HLA-based synthetic peptides. Curr Opin Immunol. 1994 Oct;6(5):791–796. doi: 10.1016/0952-7915(94)90086-8. [DOI] [PubMed] [Google Scholar]
  24. Krensky A. M., Lyu S. C., Pouletty P., Benjamin R., Parham P., Clayberger C. Peptides corresponding to the CD8 binding region of HLA class I block the differentiation of cytotoxic T lymphocyte precursors. Transplant Proc. 1993 Feb;25(1 Pt 1):483–484. [PubMed] [Google Scholar]
  25. Krensky A. M., Reiss C. S., Mier J. W., Strominger J. L., Burakoff S. J. Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+. Proc Natl Acad Sci U S A. 1982 Apr;79(7):2365–2369. doi: 10.1073/pnas.79.7.2365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lawlor D. A., Warren E., Taylor P., Parham P. Gorilla class I major histocompatibility complex alleles: comparison to human and chimpanzee class I. J Exp Med. 1991 Dec 1;174(6):1491–1509. doi: 10.1084/jem.174.6.1491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Liu J., Farmer J. D., Jr, Lane W. S., Friedman J., Weissman I., Schreiber S. L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 1991 Aug 23;66(4):807–815. doi: 10.1016/0092-8674(91)90124-h. [DOI] [PubMed] [Google Scholar]
  28. Manara G. C., Sansoni P., Badiali-De Giorgi L., Gallinella G., Ferrari C., Brianti V., Fagnoni F. F., Ruegg C. L., De Panfilis G., Pasquinelli G. New insights suggesting a possible role of a heat shock protein 70-kD family-related protein in antigen processing/presentation phenomenon in humans. Blood. 1993 Nov 1;82(9):2865–2871. [PubMed] [Google Scholar]
  29. Multhoff G., Botzler C., Wiesnet M., Müller E., Meier T., Wilmanns W., Issels R. D. A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells. Int J Cancer. 1995 Apr 10;61(2):272–279. doi: 10.1002/ijc.2910610222. [DOI] [PubMed] [Google Scholar]
  30. Nadler S. G., Tepper M. A., Schacter B., Mazzucco C. E. Interaction of the immunosuppressant deoxyspergualin with a member of the Hsp70 family of heat shock proteins. Science. 1992 Oct 16;258(5081):484–486. doi: 10.1126/science.1411548. [DOI] [PubMed] [Google Scholar]
  31. Nisco S., Vriens P., Hoyt G., Lyu S. C., Farfan F., Pouletty P., Krensky A. M., Clayberger C. Induction of allograft tolerance in rats by an HLA class-I-derived peptide and cyclosporine A. J Immunol. 1994 Apr 15;152(8):3786–3792. [PubMed] [Google Scholar]
  32. Opelz G., Terasaki P. I. Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med. 1978 Oct 12;299(15):799–803. doi: 10.1056/NEJM197810122991503. [DOI] [PubMed] [Google Scholar]
  33. Parham P., Clayberger C., Zorn S. L., Ludwig D. S., Schoolnik G. K., Krensky A. M. Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the alpha 2 domain of HLA-A2. Nature. 1987 Feb 12;325(6105):625–628. doi: 10.1038/325625a0. [DOI] [PubMed] [Google Scholar]
  34. Sigal N. H., Dumont F. J. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu Rev Immunol. 1992;10:519–560. doi: 10.1146/annurev.iy.10.040192.002511. [DOI] [PubMed] [Google Scholar]
  35. Srivastava P. K., Udono H., Blachere N. E., Li Z. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics. 1994;39(2):93–98. doi: 10.1007/BF00188611. [DOI] [PubMed] [Google Scholar]
  36. Sumimoto R., Kamada N. Evidence that soluble class I antigen in donor serum induces the suppression of heart allograft rejection in rats. Immunol Lett. 1990 Oct;26(1):81–84. doi: 10.1016/0165-2478(90)90179-t. [DOI] [PubMed] [Google Scholar]
  37. Udono H., Srivastava P. K. Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med. 1993 Oct 1;178(4):1391–1396. doi: 10.1084/jem.178.4.1391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Ullrich S. J., Robinson E. A., Law L. W., Willingham M., Appella E. A mouse tumor-specific transplantation antigen is a heat shock-related protein. Proc Natl Acad Sci U S A. 1986 May;83(10):3121–3125. doi: 10.1073/pnas.83.10.3121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. VAN ROOD J. J., VAN LEEUWEN A. LEUKOCYTE GROUPING. A METHOD AND ITS APPLICATION. J Clin Invest. 1963 Sep;42:1382–1390. doi: 10.1172/JCI104822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. VanBuskirk A. M., DeNagel D. C., Guagliardi L. E., Brodsky F. M., Pierce S. K. Cellular and subcellular distribution of PBP72/74, a peptide-binding protein that plays a role in antigen processing. J Immunol. 1991 Jan 15;146(2):500–506. [PubMed] [Google Scholar]
  41. Vanbuskirk A., Crump B. L., Margoliash E., Pierce S. K. A peptide binding protein having a role in antigen presentation is a member of the HSP70 heat shock family. J Exp Med. 1989 Dec 1;170(6):1799–1809. doi: 10.1084/jem.170.6.1799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Zemmour J., Parham P. HLA class I nucleotide sequences, 1992. Immunogenetics. 1993;37(4):239–250. doi: 10.1007/BF00187449. [DOI] [PubMed] [Google Scholar]
  43. van Twuyver E., Mooijaart R. J., ten Berge I. J., van der Horst A. R., Wilmink J. M., Kast W. M., Melief C. J., de Waal L. P. Pretransplantation blood transfusion revisited. N Engl J Med. 1991 Oct 24;325(17):1210–1213. doi: 10.1056/NEJM199110243251704. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES